send to a friend by email

JPH posts net income of $5.42 million in 9M 2023

2023-12-07

According to financial statements of Jerusalem Pharmaceuticals JPH for the first nine months of 2023, Net profit after tax of the period reached 5,419,186 USD Compared with Net profit after tax 3,900,803 USD for 2022, a net increase in profit of 38.92%.Total assets of the company reached 83,440,448 USD compared with total assets of 83,723,210 USD at the end of year 2022, a net decrease of 0.34%.Total liabilities of the company reached 19,039,194 USD compared with total liabilities of 18,491,908 USD at the end of year 2022, a net increase of 2.95%. Net ownership equity of the company reached 64,401,254 USD (Including Non-Controlling Interests of 1,017,033 USD) compared with total owner equity of 65,231,302 USD (Including Non-Controlling Interests of 964,992 USD) at the end of year 2022, a net decrease of 1.27%.